First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial (Dr K K Aggarwal)                                                                                       (Dr RN Tandon)
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
1st December, 2017
6MWT in Heart Failure

Exercise intolerance, along with dyspnea, fatigue are cardinal symptoms of heart failure, which adversely impact quality of life of the patient. Exercise improves well-being in heart failure. ESC (2016) and AHA/ACC (2013) heart failure guidelines recommend exercise to improve functional capacity, QOL and also to reduce the risk of hospitalization in stable HF patients (Class IA).

The 6-minute walk test assesses functional capacity or exercise tolerance in patients with heart failure and defines prognosis.

A 6-minute walk distance less than 200 m indicates lower functional capacity and carries a poor prognosis. If the walk distance is more than 500 m, the prognosis is good. If the 6-minute walk distance ranges between 200m and 500 m, patient can continue to exercise with oxygen supplementation.

To Read More or Comment, Click Here
Special
Video Of The Day Pediatric Emergencies
Top News

Today is World AIDS DAY: “My Health, my Right

World AIDS Day is observed every year on the 1st of December. The aim is to fight against HIV, to show support for people living with HIV, and to commemorate those who have died from an AIDS-related illness. Founded in 1988, World AIDS Day was the first ever global health day..... read more


Some Global HIV Statistics

• 19.5 million people were accessing antiretroviral therapy in 2016.
• 36.7 million (30.8 million–42.9 million) people globally were living with HIV in 2016. ..... read more

69th Annual Conference of CSI 2017 - Updates
ABCD of Pharmacological therapy in Heart Failure
  • ACEI / ARBs / ARNI and ß-blockers are neurohormonal modulators and should be used in all patients of HFrEF unless contraindicated, as they have been shown to reduce mortality and morbidity. read more

Case which stunned me in 2017 (Echo)

A patient who had suffered an anterior MI, and had PTCA and stent to mid LAD, was referred for a pre discharge echocardiogram. Echo showed wall motion abnormality in LAD territory, with mild MR...... read more


Ultrathin bioabsorbable polymer DES: New benchmark in the field of DES
  • Ultrathin strut biodegradable polymer sirolimus-eluting stents (Orsiro) are non-inferior to newer generation DES with durable polymers (Xience, Resolute) with regards to composite clinical endpoints. Recent evidence suggests superiority of Orsiro as compared to Xience with regards to target lesion failure at 12 months. read more

CTO: Tips & Tricks
  • CTO is encountered in 10-15% of all the cases who undergo coronary angiography for coronary disease. read more

Ablative therapy in ARVD and Brugada Syndrome: Is there a role?
  • Catheter ablation is feasible in patients with both ARVD and Brugada syndrome, who have recurrent ICD shocks secondary to refractory VT. read more

Circadian rhythm and timing of anti-hypertensive drugs: Any relevance?
  • Concept of circadian variation of BP has entered the clinical domain in 21st century. read more

Clinical dilemmas in lipid management
  • Diabetes is a vascular disease and most patients with diabetes die from CV complications.
  • Diabetes is associated with 2-4 fold increase in the risk of MI, stroke, CHD and heart failure. read more
 
eMedi Humor
Medicolegal Corner
eMedi Quiz
a. Mobile teledermatology
b. Videoconference
c. Store and forward teledermatology
d. Online discussion group
Lifestyle Updates
 
Inspirational Story 1: : A mountain of dirt
Pneumonia still a major cause of mortality in Indian children
Many children lack access to the Pneumococcal Conjugate Vaccine
 
New Delhi, 30 November 2017: About 20 children die every hour due to pneumonia in India, reveal recent statistics. Despite efforts being made toward universal immunization, more than 25 million children in India were not immunized with Pneumococcal Conjugate Vaccine (PCV) in 2016.Pneumonia claims more lives in children around the world than any other infectious disease. A majority of those who die are from low and middle-income countries. If this continues, the disease is likely to claim 22,587 lives 2030.
 
Pneumonia is an acute respiratory infection which affects the lungs. It causes difficulty in breathing and limits oxygen intake. It can be caused by bacteria, fungi or viruses and is a contagious disease.
To Read More or Comment, Click Here